Fibroblast Growth Factor 2 Inhibits Myofibroblastic Activation of Valvular Interstitial Cells

Investigators isolated valvular interstitial cells from diseased human valves and treated these cells with FGF-2 and TGF-β to elucidate effect of these growth factors on several myofibroblastic outcomes, in particular immunocytochemistry and gene expression.